Serious but less common risks include pancreatitis, gallbladder disease, worsening of diabetic retinopathy, kidney injury related to dehydration, and rare severe allergic reactions
Even well-informed patients and healthcare professionals can inadvertently compromise the quality of a reconstituted peptide medicine through avoidable storage errors
Before administering IGF-1 LR3, always be sure to use a clean and sterile syringe
Phase 2 trial data showed retatrutide producing up to 24.2 percent body weight loss at 48 weeks, compared to approximately 22.5 percent for tirzepatide at 72 weeks in the SURMOUNT-1 trial
Weight can stall on the scale even while your waist shrinks, especially when you are training
Receptors for GIP, GLP-1 and glucagon are present in a wide variety of organs in addition to the pancreas, including fat tissue, bone and within the brain